Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3
NCT05923177
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Primary Breast Cancer
Interventions
DRUG:
SPECT
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences